Farhat Ben Ayed

1.6k total citations
54 papers, 1.2k citations indexed

About

Farhat Ben Ayed is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Farhat Ben Ayed has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Cancer Research and 10 papers in Molecular Biology. Recurrent topics in Farhat Ben Ayed's work include Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (5 papers) and HER2/EGFR in Cancer Research (5 papers). Farhat Ben Ayed is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), BRCA gene mutations in cancer (5 papers) and HER2/EGFR in Cancer Research (5 papers). Farhat Ben Ayed collaborates with scholars based in Tunisia, France and United States. Farhat Ben Ayed's co-authors include Soumaya Kouidhi, Amel Benammar Elgaaïed, Carsten Rose, Amel Ben Ammar Elgaaïed, Patrice Viens, Amel Mézlini, Khaled Ben Romdhane, Lotfi Chouchane, Suzanne M. Johnson and A Płużańska and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Farhat Ben Ayed

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhat Ben Ayed Tunisia 17 594 385 382 271 170 54 1.2k
Slim Ben Ahmed Tunisia 17 553 0.9× 453 1.2× 322 0.8× 171 0.6× 162 1.0× 78 1.3k
Pedro Pérez‐Segura Spain 18 467 0.8× 407 1.1× 294 0.8× 237 0.9× 196 1.2× 117 1.2k
Anna Måsbäck Sweden 22 844 1.4× 423 1.1× 362 0.9× 187 0.7× 145 0.9× 48 1.8k
Zhi-Min Shao China 19 490 0.8× 405 1.1× 413 1.1× 122 0.5× 158 0.9× 46 1.1k
Eija Mahlamäki Finland 19 641 1.1× 781 2.0× 417 1.1× 309 1.1× 187 1.1× 35 1.7k
Gian Luigi Cetto Italy 19 666 1.1× 290 0.8× 369 1.0× 97 0.4× 199 1.2× 59 1.1k
Shane R. Stecklein United States 16 471 0.8× 374 1.0× 356 0.9× 151 0.6× 99 0.6× 52 934
Maria Ornella Nicoletto Italy 18 581 1.0× 496 1.3× 324 0.8× 142 0.5× 86 0.5× 54 1.3k
Ryan S. Robetorye United States 17 541 0.9× 751 2.0× 310 0.8× 237 0.9× 266 1.6× 41 1.4k
Iván Díaz-Padilla United States 21 728 1.2× 634 1.6× 392 1.0× 170 0.6× 215 1.3× 53 1.4k

Countries citing papers authored by Farhat Ben Ayed

Since Specialization
Citations

This map shows the geographic impact of Farhat Ben Ayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhat Ben Ayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhat Ben Ayed more than expected).

Fields of papers citing papers by Farhat Ben Ayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhat Ben Ayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhat Ben Ayed. The network helps show where Farhat Ben Ayed may publish in the future.

Co-authorship network of co-authors of Farhat Ben Ayed

This figure shows the co-authorship network connecting the top 25 collaborators of Farhat Ben Ayed. A scholar is included among the top collaborators of Farhat Ben Ayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhat Ben Ayed. Farhat Ben Ayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kouidhi, Soumaya, et al.. (2023). Gut microbiota, an emergent target to shape the efficiency of cancer therapy. SHILAP Revista de lepidopterología. 4(2). 240–265. 14 indexed citations
2.
Schairer, Catherine, Ahmed Hablas, Rabab Gaafar, et al.. (2019). Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa. Breast Cancer Research and Treatment. 176(2). 407–417. 13 indexed citations
3.
Blancato, Jan, David Goerlitz, Md. Sajedul Islam, et al.. (2016). Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non-Inflammatory Breast Cancer. Asian Pacific Journal of Cancer Prevention. 17(4). 1801–1810. 10 indexed citations
4.
Ayed, Farhat Ben, et al.. (2013). Adénocarcinome pulmonaire avec métastases intramédullaires : à propos d’un cas et revue de la littérature. Revue de Pneumologie Clinique. 69(3). 149–151. 3 indexed citations
5.
Kourda, Nadia, Amel Mézlini, Farid Zerimech, et al.. (2011). Lynch syndrome in Tunisia: first description of clinical features and germline mutations. International Journal of Colorectal Disease. 26(4). 455–467. 13 indexed citations
6.
Fumoleau, P., H. Cortés-Funes, Stephen Chan, et al.. (2009). Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy. American Journal of Clinical Oncology. 32(4). 375–380. 29 indexed citations
7.
Fakhfakh, R., et al.. (2008). La consultation d’aide au sevrage tabagique de l’institut de cancérologie Salah-Azeiz de Tunis : résultats à un an. Revue d Épidémiologie et de Santé Publique. 56(4). 280–285. 4 indexed citations
8.
Charafe‐Jauffret, Emmanuelle, Karima Mrad, Sana Intidhar Labidi‐Galy, et al.. (2007). Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. The Breast. 16(4). 352–358. 15 indexed citations
9.
Mézlini, Amel, et al.. (2007). Inflammatory breast cancer in Tunisia in the era of multimodality therapy. Annals of Oncology. 19(3). 473–480. 31 indexed citations
10.
Feng, Bing, Majida Jalbout, Meriem Khyatti, et al.. (2007). Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. International Journal of Cancer. 121(7). 1550–1555. 67 indexed citations
11.
Soliman, Amr S., Sofía D. Merajver, Kadry Ismail, et al.. (2006). Knowledge Gained After a Brief CME Module on Breast Cancer Diagnosis. Journal of Cancer Education. 21(3). 169–174. 16 indexed citations
12.
Mrad, Karima, et al.. (2005). Esthesioneuroblastoma Metastatic to the Breast in a Young Woman. Acta Cytologica. 49(4). 427–430. 6 indexed citations
13.
Mansouri, Davood, et al.. (2005). Hémangio-endothéliome épithélioïde des tissus mous. Revue de Chirurgie Orthopédique et Réparatrice de l Appareil Moteur. 91(7). 671–675. 2 indexed citations
14.
Maâlej, M., et al.. (2004). Cervical cancer in Tunisia: an epidemiological, clinical and pathological study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 113(2). 226–228. 17 indexed citations
15.
Rose, Carsten, A Płużańska, Nancy E. Davidson, et al.. (2003). An open randomised trial of second-line endocrine therapy in advanced breast cancer. European Journal of Cancer. 39(16). 2318–2327. 145 indexed citations
16.
Ayed, Farhat Ben, et al.. (2002). [Dispensation of opioids by pharmacists in Tunisia].. PubMed. 56(6). 711–7. 1 indexed citations
17.
Kochbati, Lotfi, Hamouda Boussen, M. Besbes, et al.. (2001). Fibrosarcome secondaire de la mandibule après chimioradiothérapie pour carcinome indifférencié du nasopharynx. À propos d’une observation et revue de la littérature. Cancer/Radiothérapie. 5(3). 283–286. 4 indexed citations
18.
Maâlej, M., et al.. (1993). Emergence of non-major-histocompatibility-complex-restricted lytic CD8+ cells in the blood of nasopharyngeal carcinoma patients. Cancer Immunology Immunotherapy. 37(2). 131–139. 3 indexed citations
19.
Dellagi, Koussay, et al.. (1992). α Heavy chain disease αmRNA contain nucleotide sequences of unknown origins. European Journal of Immunology. 22(11). 3037–3040. 5 indexed citations
20.
Amiel, Jeanne, et al.. (1980). Maladie de Hodgkin. Possibilité d'une chimiothérapie de secours après échec du traitement classique.. ˜La œNouvelle presse médicale. 9(37). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Slim Ben Ahmed Breakdown of academic impact, for papers by Pedro Pérez‐Segura Breakdown of academic impact, for papers by Anna Måsbäck Breakdown of academic impact, for papers by Zhi-Min Shao Breakdown of academic impact, for papers by Eija Mahlamäki Breakdown of academic impact, for papers by Gian Luigi Cetto Breakdown of academic impact, for papers by Shane R. Stecklein Breakdown of academic impact, for papers by Maria Ornella Nicoletto Breakdown of academic impact, for papers by Ryan S. Robetorye Breakdown of academic impact, for papers by Iván Díaz-Padilla
Rankless by CCL
2026